Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma

Saved in:
Bibliographic Details
Main Authors: Wolf, Jeffrey L. (Author) , Goldschmidt, Hartmut (Author)
Format: Article (Journal)
Language:English
Published: 01 Mar 2012
In: Leukemia and lymphoma
Year: 2012, Volume: 53, Issue: 9, Pages: 1820-1823
ISSN:1029-2403
DOI:10.3109/10428194.2012.661175
Online Access:Verlag, Volltext: http://dx.doi.org/10.3109/10428194.2012.661175
Verlag, Volltext: https://doi.org/10.3109/10428194.2012.661175
Get full text
Author Notes:Jeffrey L. Wolf, David Siegel, Hartmut Goldschmidt, Katharine Hazell, Priscille M. Bourquelot, Bourras R. Bengoudifa, Jeffrey Matous, Ravi Vij, Margarida de Magalhaes-Silverman, Rafat Abonour, Kenneth C. Anderson & Sagar Lonial
Description
Item Description:Gesehen am 01.10.2018
Physical Description:Online Resource
ISSN:1029-2403
DOI:10.3109/10428194.2012.661175